Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
CPT: Pharmacometrics & Systems Pharmacology|September 20, 2022
Dose/exposure-response modeling in dose titration trials: Overcoming the titration paradoxNiels Rode Kristensen, Henrik Agersø
Journal of Pharmacokinetics and Pharmacodynamics|October 11, 2005
Using stochastic differential equations for PK/PD model developmentNiels Rode Kristensen, Henrik Madsen, Steen Hvass Ingwersen
Computer Methods and Programs in Biomedicine|March 10, 2009
Population stochastic modelling (PSM)--an R package for mixed-effects models based on stochastic differential equationsSøren Klim, Stig Bousgaard Mortensen, Niels Rode Kristensen, et al.
Diabetes, Obesity & Metabolism|February 21, 2024
Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 1 diabetesUlrike Hövelmann, Susanne Engberg, Tim Heise, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 9, 2011
Clearance of rFVIIa and NN1731 after intravenous administration to Beagle dogsHenrik Agersø, Niels Rode Kristensen, Henrik Østergaard, et al.
Journal of Diabetes Investigation|December 12, 2024
Pharmacological characteristics of once-weekly insulin icodec in Japanese individuals with type 1 diabetesTakashi Eto, Miwa Haranaka, Niels Rode Kristensen, et al.
Clinical Drug Investigation|January 11, 2023
Pharmacokinetic and Pharmacodynamic Characteristics of Insulin Icodec After Subcutaneous Administration in the Thigh, Abdomen or Upper Arm in Individuals with Type 2 Diabetes MellitusLeona Plum-Mörschel, Lizette Ravn Andersen, Solvejg Hansen, et al.
Pediatric Diabetes|January 29, 2014
Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetesTorben Biester, Sarah Blaesig, Kerstin Remus, et al.
BMJ Open Diabetes Research & Care|August 20, 2021
Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosingErica Nishimura, Lone Pridal, Tine Glendorf, et al.
Clinical Pharmacology and Therapeutics|March 23, 2024
Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting ProgramGerald R Galluppi, Malidi Ahamadi, Souvik Bhattacharya, et al.
Pageof 1